ADLAI NORTYE ANNOUNCES FIRST PATIENT DOSED IN AUSTRALIA AND U.S. FDA IND CLEARANCE FOR AN4035, A FIRST-IN-CLASS PAN-RAS(ON) INHIBITOR-BASED ADC

Reuters · 1d ago

Please log in to view news